These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 36773822)

  • 1. Tumor necrosis factor inhibitors and methotrexate are associated with decreased COVID-19-related hospitalization: Follow up of "Clinical outcomes of COVID-19 in patients taking tumor necrosis factor inhibitors and methotrexate".
    Cahn RT; Zinn Z; Kolodney MS
    J Am Acad Dermatol; 2023 Jun; 88(6):1385-1386. PubMed ID: 36773822
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical outcomes of COVID-19 in patients taking tumor necrosis factor inhibitors or methotrexate: A multicenter research network study.
    Yousaf A; Gayam S; Feldman S; Zinn Z; Kolodney M
    J Am Acad Dermatol; 2021 Jan; 84(1):70-75. PubMed ID: 32926977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association Between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19.
    Izadi Z; Brenner EJ; Mahil SK; Dand N; Yiu ZZN; Yates M; Ungaro RC; Zhang X; Agrawal M; Colombel JF; Gianfrancesco MA; Hyrich KL; Strangfeld A; Carmona L; Mateus EF; Lawson-Tovey S; Klingberg E; Cuomo G; Caprioli M; Cruz-Machado AR; Mazeda Pereira AC; Hasseli R; Pfeil A; Lorenz HM; Hoyer BF; Trupin L; Rush S; Katz P; Schmajuk G; Jacobsohn L; Seet AM; Al Emadi S; Wise L; Gilbert EL; Duarte-García A; Valenzuela-Almada MO; Isnardi CA; Quintana R; Soriano ER; Hsu TY; D'Silva KM; Sparks JA; Patel NJ; Xavier RM; Marques CDL; Kakehasi AM; Flipo RM; Claudepierre P; Cantagrel A; Goupille P; Wallace ZS; Bhana S; Costello W; Grainger R; Hausmann JS; Liew JW; Sirotich E; Sufka P; Robinson PC; Machado PM; Griffiths CEM; Barker JN; Smith CH; Yazdany J; Kappelman MD; ;
    JAMA Netw Open; 2021 Oct; 4(10):e2129639. PubMed ID: 34661663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor necrosis factor inhibitors are associated with a decreased risk of COVID-19-associated hospitalization in patients with psoriasis-A population-based cohort study.
    Kridin K; Schonmann Y; Damiani G; Peretz A; Onn E; Bitan DT; Cohen AD
    Dermatol Ther; 2021 Jul; 34(4):e15003. PubMed ID: 34033207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD4
    Popescu I; Snyder ME; Iasella CJ; Hannan SJ; Koshy R; Burke R; Das A; Brown MJ; Lyons EJ; Lieber SC; Chen X; Sembrat JC; Bhatt P; Deng E; An X; Linstrum K; Kitsios G; Konstantinidis I; Saul M; Kass DJ; Alder JK; Chen BB; Lendermon EA; Kilaru S; Johnson B; Pilewski JM; Kiss JE; Wells AH; Morris A; McVerry BJ; McMahon DK; Triulzi DJ; Chen K; Sanchez PG; McDyer JF
    Am J Respir Crit Care Med; 2022 Jun; 205(12):1403-1418. PubMed ID: 35348444
    [No Abstract]   [Full Text] [Related]  

  • 6. Waning humoral and cellular immunity after COVID-19 vaccination in patients with psoriasis treated with methotrexate and biologics: a cohort study.
    Kvist-Hansen A; Pérez-Alós L; Al-Sofi RF; Heftdal LD; Hamm SR; Møller DL; Pries-Heje MM; Fogh K; Hansen CB; Hasselbalch RB; Madsen JR; Armenteros JJA; Frikke-Schmidt R; Hilsted L; Sørensen E; Ostrowski SR; Bundgaard H; Nielsen SD; Iversen K; Zachariae C; Garred P; Skov L
    Br J Dermatol; 2023 Apr; 188(5):661-669. PubMed ID: 36703193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of anti-drug antibodies against tumor necrosis factor inhibitors with addition of immunomodulators: A systematic review and meta-analysis.
    Dhindsa BS; Dhaliwal A; Mashiana HS; Saghir SM; Sayles H; Mubder M; Ohning G; Eichele D
    Indian J Gastroenterol; 2020 Apr; 39(2):153-160. PubMed ID: 32468382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Biological therapy after COVID-19 infection : No reactivation of a COVID-19 infection with positive SARS-CoV-2 antibody status under biological therapy].
    Steinchen N; Müller-Ladner U; Lange U
    Z Rheumatol; 2020 Aug; 79(6):574-577. PubMed ID: 32514854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective Roles of Tumor Necrosis Factor-Alpha (TNF-α) in COVID-19: Prognosis, Therapeutic and Management.
    Mohd Zawawi Z; Kalyanasundram J; Mohd Zain R; Thayan R; Basri DF; Yap WB
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of tumor necrosis factor-α in the mortality of hospitalized patients with severe and critical COVID-19 pneumonia.
    Jia F; Wang G; Xu J; Long J; Deng F; Jiang W
    Aging (Albany NY); 2021 Nov; 13(21):23895-23912. PubMed ID: 34725309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry.
    Brenner EJ; Ungaro RC; Gearry RB; Kaplan GG; Kissous-Hunt M; Lewis JD; Ng SC; Rahier JF; Reinisch W; Ruemmele FM; Steinwurz F; Underwood FE; Zhang X; Colombel JF; Kappelman MD
    Gastroenterology; 2020 Aug; 159(2):481-491.e3. PubMed ID: 32425234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor necrosis factor alpha inhibitors, methotrexate or both? An inquiry into the formal evidence for when they are to be used in rheumatoid arthritis.
    Yazici Y; Yazici H
    Clin Exp Rheumatol; 2008; 26(3):449-52. PubMed ID: 18578967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and tolerability of the COVID-19 messenger RNA vaccine in adolescents with juvenile idiopathic arthritis treated with tumor necrosis factor inhibitors.
    Dimopoulou D; Spyridis N; Vartzelis G; Tsolia MN; Maritsi DN
    Arthritis Rheumatol; 2022 Feb; 74(2):365-366. PubMed ID: 34492161
    [No Abstract]   [Full Text] [Related]  

  • 14. Real-World Outcomes Associated With Methotrexate, Sulfasalazine, and Hydroxychloroquine Triple Therapy Versus Tumor Necrosis Factor Inhibitor/Methotrexate Combination Therapy in Patients With Rheumatoid Arthritis.
    Curtis JR; Palmer JL; Reed GW; Greenberg J; Pappas DA; Harrold LR; Kremer JM
    Arthritis Care Res (Hoboken); 2021 Aug; 73(8):1114-1124. PubMed ID: 32374918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcomes of patients with COVID-19 and inflammatory rheumatic diseases receiving biological/targeted therapy.
    Pehlivan Ö; Aydin T
    Ann Saudi Med; 2022; 42(3):155-164. PubMed ID: 35658585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of Tumor Necrosis Factor Inhibitors During the COVID-19 Pandemic-Evidence in Favor of Monotherapy.
    Velloso LA
    JAMA Netw Open; 2021 Oct; 4(10):e2129707. PubMed ID: 34661668
    [No Abstract]   [Full Text] [Related]  

  • 17. Antibody Response to SARS-CoV-2 Vaccination in Patients with Inflammatory Bowel Disease: Results of a Single-Center Cohort Study in a Tertiary Hospital in Germany.
    Classen JM; Muzalyova A; Nagl S; Fleischmann C; Ebigbo A; Römmele C; Messmann H; Schnoy E
    Dig Dis; 2022; 40(6):719-727. PubMed ID: 34915480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity 6 months post COVID-19 mRNA vaccination among adolescents with juvenile idiopathic arthritis on treatment with TNF inhibitors.
    Dimopoulou D; Tsolia MN; Spyridis N; Maritsi DN
    Rheumatology (Oxford); 2023 Feb; 62(SI2):SI205-SI209. PubMed ID: 35788275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence, admission rates and hypoxia due to COVID-19 in patients with rheumatic disorders treated with targeted synthetic or biologic disease modifying antirheumatic drugs or methotrexate: a nationwide study from Iceland.
    Bjornsson AH; Grondal G; Kristjansson M; Jonsdottir T; Love TJ; Gudbjornsson B;
    Ann Rheum Dis; 2021 May; 80(5):671-672. PubMed ID: 33402343
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical features and outcomes of COVID-19 in patients with rheumatic diseases treated with biological and synthetic targeted therapies.
    Sanchez-Piedra C; Diaz-Torne C; Manero J; Pego-Reigosa JM; Rúa-Figueroa Í; Gonzalez-Gay MA; Gomez-Reino J; Alvaro-Gracia JM;
    Ann Rheum Dis; 2020 Jul; 79(7):988-990. PubMed ID: 32503857
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.